Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

423 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Does systemic anti-tumor therapy increase COVID-19 risk in patients with cancer?
Ayhan M, Laçin Ş, Özyükseler DT, Sürmeli H, Doğan A, Turan M, Odabas H, Turan N, Yıldırım ME. Ayhan M, et al. Among authors: turan n, turan m. J Oncol Pharm Pract. 2021 Sep;27(6):1461-1467. doi: 10.1177/10781552211015762. Epub 2021 May 7. J Oncol Pharm Pract. 2021. PMID: 33961521 Free PMC article.
Does the efficacy of regorafenib differ in chemotherapy refractory metastatic colorectal cancer patients who had mucinous pathology compared to those who had non-mucinous pathology?
Ayhan M, Turan N, Köstek O, Tufan G, Tataroğlu Özyükseler D, Odabas H, Sakin A, Turan M, Sürmeli H, Yıldırım ME. Ayhan M, et al. Among authors: turan n, turan m. Curr Probl Cancer. 2021 Jun;45(3):100670. doi: 10.1016/j.currproblcancer.2020.100670. Epub 2020 Oct 22. Curr Probl Cancer. 2021. PMID: 33129567
Perspective of Turkish Medicine Students on Cancer, Cancer Treatments, Palliative Care, and Oncologists (ARES Study): a Study of the Palliative Care Working Committee of the Turkish Oncology Group (TOG).
Oktay E, Levent M, Gelincik H, Aktaş G, Yumuk F, Koral L, Arpacı E, Keser M, Alkan A, Karci E, Karadurmuş N, Degirmencioglu S, Turan M, Uyeturk U, Cabuk D, Avci N, Toprak O, Ergen A, Urvay S, Bayman E, Petekkaya E, Nayir E, Paydaş S, Yavuzsen T, Senler FC, Yaren A, Barutca S, Şahinler İ, Ozyilkan O, Tanriverdi O. Oktay E, et al. Among authors: turan m. J Cancer Educ. 2020 Feb;35(1):69-75. doi: 10.1007/s13187-018-1441-6. J Cancer Educ. 2020. PMID: 30446981
Real-Life Analysis of Efficacy and Safety of Everolimus Plus Exemestane in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor-2-Negative Metastatic Breast Cancer Patients: A Turkish Oncology Group (TOG) Study.
Bilici A, Uysal M, Menekse S, Akin S, Yildiz F, Turan M, Sezgin Goksu S, Beypinar I, Sakalar T, Değirmenci M, Erdem D, Basaran G, Olmez OF, Avci N, Tural D, Sakin A, Turker S, Demir A, Temiz S, Kaplan MA, Dogan M, Tanriverdi O, Bilgetekin I, Cinkir HY, Acikgoz O, Paydas S, Uslu R, Turhal S. Bilici A, et al. Among authors: turan m. Cancer Invest. 2022 Feb;40(2):199-209. doi: 10.1080/07357907.2021.2017952. Epub 2021 Dec 22. Cancer Invest. 2022. PMID: 34894960
Expression of CD44, PCNA and E-cadherin in pterygium tissues.
Yıldırım H, Turan G, Turan M. Yıldırım H, et al. Among authors: turan m. Indian J Ophthalmol. 2024 May 1;72(Suppl 3):S501-S504. doi: 10.4103/IJO.IJO_2579_23. Epub 2024 Apr 20. Indian J Ophthalmol. 2024. PMID: 38648458 Free article.
Can the ADO Index Be Used as a Predictor of Mortality from COVID-19 in Patients with COPD?
Yazar EE, Gunluoglu G, Arpinar Yigitbas B, Calikoglu M, Gulbas G, Yılmaz Demirci N, Sarioglu N, Bozkus F, Hoca NT, Ogan N, Tural Onur S, Turan MO, Kosar F, Akpinar EE, Mete B, Ozturk C. Yazar EE, et al. Among authors: turan mo. Int J Chron Obstruct Pulmon Dis. 2024 Apr 4;19:851-858. doi: 10.2147/COPD.S440099. eCollection 2024. Int J Chron Obstruct Pulmon Dis. 2024. PMID: 38596202 Free PMC article.
423 results